The Flourishing German Cannabinoid Market

landscape of Germany's cannabinoid market

Table of Contents

Germany, a nation with a rich tapestry of traditions, is globally recognized for its unparalleled medical advancements. Given this background, cannabinoids seem like a natural fit. However, the journey towards a robust German cannabinoid market faces certain challenges.

Individual businesses, armed with specific knowledge and strategic moves, are the forerunners in overcoming these barriers and driving the growth of Germany’s cannabinoid sector. But what is the current landscape of Germany’s cannabinoid market? How does the legal framework shape its trajectory?

Legality of Cannabinoids in Germany

Cannabinoids, in specific scenarios, are permitted in Germany. Reflecting the EU’s stance, non-food CBD products containing below 0.2% THC (delta-9 tetrahydrocannabinol) generally enjoy a relatively unrestricted sale in Germany.

Moreover, revisions to Germany’s adult-use and medicinal cannabis laws are under consideration in the Bundestag. The focus is on two draft bills: one enabling German adults to possess cannabis reasonably and the other proposing cannabis’s removal from the German narcotics code, Betäubungsmittelgesetz (BtMG).

However, overarching EU regulations limit Germany’s cannabis legalization scope, affecting inter-country economic ties. Initial drafts suggested commercial sales, but revisions now favor personal possession and the creation of “grower clubs” with member caps.

In the European context, Germany is progressively embracing cannabinoids. Yet, it also exemplifies challenges prevalent in the European market – challenges which sustained investment in the German cannabinoid sector is poised to mitigate.

Germany’s Deep-rooted Cannabis Connection

Germany’s bond with cannabis is ancient. Evidences, like cannabis seeds found in a 500 BC Wilmersdorf funerary urn, suggest its use dates back over 7,500 years. Historically, from ancient alchemists to Enlightenment-era doctors, Germany has pioneered cannabis’s understanding and medicinal applications more than most nations.

Recently, the perspective on cannabis has shifted globally, but Germany’s age-old reverence for the plant sets it apart in Europe.

The Evolution of Cannabis Laws in Germany

Cannabis entered German legal discourse in 1981 via the BtMG, a narcotics law. Although this law initially restricted cannabis-related activities, Germany was relatively liberal with its drug enforcement strategies.

A significant legislative turn came in 2007 when Germany, honoring its historic relationship with the plant, legalized medical cannabis. This move was expansive by 2017, significantly benefiting the German cannabinoid market. The industry witnessed remarkable growth, with the number of cannabis users surging from 600,000 in 2017 to over 6.7 million by 2022.

Which Cannabinoids are Approved in Germany?


In line with German and EU laws, CBD remains legal. The BtMG doesn’t explicitly list CBD, and EU guidelines maintain that cannabis containing under 0.3% THC is industrial, not intoxicating. However, Germany views various CBD products differently, for instance, CBD edibles are restricted.


Cannabigerol (CBG), a cousin of CBD, hasn’t gained significant traction in Germany yet. The main goal is to introduce CBG without unsettling regulatory bodies or drawing parallels with THC.


THC in Germany is primarily legal within the confines of medical cannabis, which can only be obtained via a state-managed pharmacy with a doctor’s prescription. Complete commercial sales are still constrained.

German cannabis market

Adult-Use Cannabis in Germany

Recreational or adult-use cannabis is currently illegal. For possession, one needs medical authorization or the product must adhere to the EU’s THC threshold.

Cannabinoid Import in Germany

Imports follow EU norms. Industrial hemp-based cannabinoid products are generally allowed, while THC-rich products face stricter regulations.

Cannabinoid Production in Germany

Production within Germany is mostly restricted to research or medical intentions. Notably, many international manufacturers operate in neighboring countries to serve the German market.

Looking Ahead: Germany’s Cannabinoid Potential

Germany’s multifaceted history and deference to EU norms sometimes eclipse its unique cultural identity. Especially regarding cannabis, Germany’s relationship is distinct and calls for lifting restrictions.

Appealing to the German ethos and acknowledging their historical ties with cannabis can catalyze a more inclusive and accepting cannabinoid market. Over time, with a strategic and informed approach, Germany stands poised to dominate the European cannabis scene.

In conclusion, while the German cannabinoid industry navigates present complexities, a promising horizon awaits, driven by the sector’s trailblazers

Share this post with your colleagues and friends

Share on linkedin
Share on facebook
Share on twitter
Share on email
Share on whatsapp

You may also be interested in ...

THCH Effects
Dave Densley

What Is THCH? Production, Effects, Risks, And Comparison With Other Cannabinoids

Maybe you’ve heard about THC, the active component of marijuana. But, have you ever heard of THCH before? It is a synthetic cannabinoid that is said to be 100 times stronger than THC. If you are interested in knowing more information about this strange compound, then stay tuned! In this text, we will explain everything there is to know about THCH.

Charlotte de Ridder

How to start a cannabinoid business in Europe?

Starting a cannabinoid business in Europe involves navigating a complex web of legal, financial, and operational challenges. The evolving nature of cannabis laws across European countries means entrepreneurs must be diligent in their research and compliance efforts. This article outlines a broad framework for launching a cannabinoid business in Europe, covering legal considerations, market research, business planning, licensing and regulations, finding suppliers, branding and marketing, and establishing a customer base.

Bas van Engelen

How does cannabinoids work in the human body?

The Symphony of Cannabinoids and the Human Body: Understanding CB1 and CB2 Receptors. In the intricate dance of biology, few systems are as compelling as the endocannabinoid system (ECS), a complex network of receptors, enzymes, and endogenous cannabinoids (endocannabinoids) that play a pivotal role in maintaining the body’s internal balance, or homeostasis. But what happens when external cannabinoids, such as those found in cannabis, enter the fray? The key to this interaction lies in two critical receptors: cannabinoid receptor type 1 (CB1) and type 2 (CB2). Let’s delve into the science of how cannabinoids and these receptors orchestrate a myriad of physiological effects.

You are here: